News & Press Releases
Filter by:
Mintz Appoints Head of Innovation, AI, and E-Data Consulting
March 24, 2025
Mintz announces the appointment of John B. Koss as Head of Innovation, AI, and E-Data Consulting. Drawing on over 20 years of legal and technology experience, John will lead Mintz’s efforts in exploring how the firm can use AI and other emerging technologies to further advance client service and operational efficiency.
Mintz Advises Lightkeeper in Growth Investment from PSG
March 21, 2025
Mintz advised Lightkeeper, a leading provider of data, analytics, risk management, and reporting solutions for investment managers, in a growth investment from PSG, a growth equity firm focused on software and technology-enabled services companies.
Three Mintz Members have been selected to serve on Law360’s 2025 Editorial Advisory Boards in their respective practice areas. The editorial advisory boards provide feedback on Law360’s coverage and expert insight on how best to shape future coverage.
Mintz Advises SightLine on its Acquisition of Athena AI
March 12, 2025
Mintz advised SightLine Applications, a leading developer of sensor processing software for autonomous and uncrewed systems, backed by Artemis, on its acquisition of Athena AI, an Australia-based specialist in AI-enabled computer vision and decision support for defense applications.
JD Supra has recognized ten Mintz attorneys in its 2025 Readers’ Choice Awards. The awards recognize attorneys and firms whose articles on the JD Supra platform were most read by C-suite executives, in-house counsel, media, and other professionals during 2024.
Mintz is a finalist for the “Life Sciences IP Firm of the Year” category in the inaugural Life Sciences Patent Network (LSPN) Awards USA 2025. The awards are organized by Life Sciences Intellectual Property Review and celebrate excellence across the industry—from trailblazing individuals to firms redefining the boundaries of life sciences IP. Judged by an independent panel of experts, the program highlights innovation, dedication, and the unsung heroes driving progress in the life sciences patent community.